Advertisement
Screener

20/20 BIOLABS, INC. (AIDX) Form D

20/20 BIOLABS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2016-02-04: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-01-28; Total offering amount $3,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2016-02-04Rule 506(b)Equity2016-01-28$3,000,000$2,000,000$1,000,0001

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGENOMICS INC (NEO)United States$2.514B-35.96